Filing analysis / Ownership / Schenkein David P

Top 10 companies

Schenkein David P		109
AGIO Agios Pharmaceuticals		72
DNLI Denali Therapeutics		17
BLUE bluebird bio		9
REGN Regeneron Pharmaceuticals		4
FMI Foundation Medicine Inactive		4
PRME Prime Medicine		3

Relative stock performance:

1M 3M 6M 1Y

Search information

Ownership

Filing Types

Schenkein David P

People

SEC filings

Source

By filing date (month)

Mar 2015

Dec 2024

By filing type

4		100
144		3
3		3
4/A		3

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.